Trial Profile
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191(NCI)/IC-200403(INCIENSA) [EXTENSION OF 700010066]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary) ; Alum; AS04A; Hepatitis A-hepatitis B vaccine; Hepatitis B vaccine
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Hepatitis A; Hepatitis B; Human papillomavirus infections
- Focus Therapeutic Use
- 09 Apr 2013 New trial record
- 01 Apr 2013 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.